Compugen Ltd

NASDAQ:CGEN   4:00:00 PM EDT
2.54
+0.04 (+1.60%)
: $2.42 -0.12 (-4.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)227.41M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.43 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$2.59
50-Day MA$2.43
200-Day MA$1.41
See more pivots

Compugen Ltd Stock, NASDAQ:CGEN

Azrieli Center, 26 Harokmim Street, Holon, Tel Aviv 58858
Israel
Phone: +972.3.765.8585
Number of Employees: 68

Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.